The list of non-GLP1RA anti-diabetes medications included insulins, metformin, sulfonylureas, alpha glucosidase inhibitors, thiazolidinediones, dipeptidyl peptidase 4 (DPP-4) inhibitors, sodium-glucose co-transporter 2 (SGLT2) inhibitors
n = 39) for 10 weeks before organoid orthotopic implantation and for the entire duration of the experiment
Immunohistochemical analysis has revealed GLP-1 R expression in the acinar and ductal epithelium of the lacrimal gland, although this expression is significantly downregulated in diabetic models
Switching between GLP-1 drugs does not eliminate the underlying mechanism causing these injuries
Retatrutide, with its multi-receptor action, influences glucose regulation, insulin sensitivity, and appetite signals
Have I tried diet and exercise with limited success